Innovation leaders guide the way
Two key leaders are crucial to the Zucker Institute’s success.
JESSE GOODWIN Zucker Institute Board Chair and MUSC Chief Innovation Officer
Dr. Goodwin has spent more than a decade engaged in innovation across a broad range of medical therapies, with applications in academia and industry. She has a demonstrated track record for driving improved
outcome metrics. Prior to accepting the role of Chief Innovation Officer at MUSC, Goodwin was Vice President of Development and Deputy Director for the organizations that combined to create the Zucker Institute.
“The Zucker Institute plays a critical role in advancing MUSC generated ideas and discoveries into tangible solutions addressing today’s biggest health challenges. It is a key ingredient of what makes MUSC’s innovation culture as special as it is.”
ANAND MEHTA Interim Vice President of Research, MUSC, and Zucker Institute Board Member
Dr. Mehta serves as MUSC’s Interim Vice President for Research, overseeing all its associated divisions, which include responsibility for accreditation and regulatory affairs, university-wide promotion of research across
all colleges and centers, representing the president and provost on internal and external research matters, and identifying institutional research strategies and benchmarks in relation to the MUSC strategic plan.
“The move from idea in a laboratory to products in the marketplace is often a significant challenge. I’m proud to be part of an institution that has mentored inventors and innovators and helped develop these ideas into realistic products and businesses.”
8
9
FY2024 ANNUAL REPORT
FROM IDEA TO MARKETPLACE
Made with FlippingBook - PDF hosting